JKT:PEHA

PT Phapros, Tbk · JKT · Healthcare · IDR · FY for 2025

Figures on this page computed 2026-11-08 12:26 UTC

Last close

n/aIDR

Market data

7.9xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
IDR
- computed
- Computed from the filing for 2025
5.2%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
IDR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
3.0%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
IDR
- Computed from the filing for 2025
- Computed from the filing for 2025
6.9%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
IDR
- Computed from the filing for 2025
- Computed from the filing for 2025
1.70Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
IDR
- Computed from the filing for 2025
- Computed from the filing for 2025
0.004%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
IDR
- computed

Safety is the furthest below its sector's middle: 0.33 against 0.57 on the market's range.

All from 100

lens 2 of 9

Sales

115

2016-12-31 to 2025-12-31100 at the start115

Sales: 100.00 on 2016-12-31 to 115.29 on 2025-12-31, up 15%.

Profit

32.2

2016-12-31 to 2025-12-31100 at the start32.2

Profit: 100.00 on 2016-12-31 to 32.22 on 2025-12-31, down 68%.

Shares in issue

100

2016-12-31 to 2025-12-31100 at the start100

Shares in issue: 100.00 on 2016-12-31 to 100.00 on 2025-12-31, up 0%.

Sales is at 115, Profit is at 32, Shares in issue is at 100, against 100 in 2016.

Sales is at 115, Profit is at 32, Shares in issue is at 100, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 100115
Source
computed
Statement
income
Fiscal year
2025
Reported in
IDR
Profit, where the first year is 10032
Source
computed
Statement
income
Fiscal year
2025
Reported in
IDR
Shares in issue, where the first year is 100100
Source
computed
Statement
income
Fiscal year
2025
Reported in
IDR